Impact of Montelukast as Add on Treatment to the Novel Coronavirus Pneumonia (Covid-19): Protocol for an Investigator-Initiated Open Labeled Randomized Controlled Pragmatic Trial
AuthID
P-015-E1G
P-015-E1G